CIK: 0001586444
Total reported value
$146.8M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ISRG | Intuitive Surgical INC | Stock-Healthcare | 6.81% | +3.19% | NEW | |
| 2 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 6.72% | +1.26% | +67.57% | |
| 3 | ✓ | Shire PLC | Stock-Other | 6.36% | — | — | |
| 4 | BIIB | Biogen INC | Stock-Healthcare | 6.01% | -6.23% | EXIT | |
| 5 | ✓ | Stock-Other | 5.26% | — | — | ||
| 6 | ✓ | Stock-Other | 5.07% | — | — | ||
| 7 | CERNCHF | Cerner CORP | Stock-Other | 4.39% | — | +20.19% | |
| 8 | NVROEUR | Nevro CORP | Stock-Other | 4.32% | +0.72% | — | |
| 9 | IPXLEUR | Impax Laboratories INC | Stock-Other | 4.25% | — | — | |
| 10 | HO1 | Hologic INC | Stock-Other | 4.25% | — | — | |
| 11 | DGX | Quest Diagnostics INC | Stock-Healthcare | 4.20% | — | — | |
| 12 | COO | The Cooper Companies, Inc. | Stock-Healthcare | 4.07% | — | -25.00% | |
| 13 | A | Agilent Technologies INC | Stock-Healthcare | 4.02% | — | — | |
| 14 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 3.81% | -5.35% | EXIT | |
| 15 | NBIX | Neurocrine Biosciences INC | Stock-Healthcare | 3.81% | +4.55% | NEW | |
| 16 | ✓ | Wright Medical Group NV | Stock-Other | 3.67% | +1.32% | — | |
| 17 | ✓ | Cepheid | Stock-Other | 3.57% | — | -6.12% | |
| 18 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 3.39% | -0.25% | -42.07% | |
| 19 | QGEN | Qiagen N.V. | Stock-Healthcare | 3.36% | -5.55% | EXIT | |
| 20 | ✓ | Depomed INC | Stock-Other | 3.27% | — | — | |
| 21 | PRGO | Perrigo Company plc | Stock-Healthcare | 3.20% | — | -42.96% | |
| 22 | ✓ | St Jude Med INC | Stock-Other | 3.18% | — | — | |
| 23 | MASI* | Masimo CORP | Stock-Other | 3.01% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ISRG | Intuitive Surgical INC | +1.4% | +23.33% | Add |
| 2 | BIIB | Biogen INC | +1.1% | +36.85% | Add |
| 3 | CERNCHF | Cerner CORP | +0.2% | +20.19% | Add |
| 4 | QGEN | Qiagen N.V. | -1% | -15.29% | Trim |
| 5 | EW | Edwards Lifesciences CORP | -1.7% | +67.57% | Add |
| 6 | ✓ | Cepheid | -1.9% | -6.12% | Trim |
| 7 | VRTX | Vertex Pharmaceuticals INC | -2.3% | -42.07% | Trim |
| 8 | COO | The Cooper Companies, Inc. | -3% | -25.00% | Trim |
| 9 | PRGO | Perrigo Company plc | -3.9% | -42.96% | Trim |
| 10 | ✓ | Shire PLC | — | NEW | New buy |
| 11 | INCY | Incyte CORP | — | EXIT | Sold out |
| 12 | ✓ | — | NEW | New buy | |
| 13 | ✓ | — | NEW | New buy | |
| 14 | BMRN | Biomarin Pharmaceutical INC | — | EXIT | Sold out |
| 15 | ALXN | Alexion Pharmaceuticals INC | — | EXIT | Sold out |
| 16 | NUVAGBP | Nuvasive INC | — | EXIT | Sold out |
| 17 | WCGEUR | Wellcare Health Plans INC | — | EXIT | Sold out |
| 18 | BKD | Brookdale Senior Living INC | — | EXIT | Sold out |
| 19 | NVROEUR | Nevro CORP | — | NEW | New buy |
| 20 | CNC | Centene CORP | — | EXIT | Sold out |
| 21 | IPXLEUR | Impax Laboratories INC | — | NEW | New buy |
| 22 | HO1 | Hologic INC | — | NEW | New buy |
| 23 | DGX | Quest Diagnostics INC | — | NEW | New buy |
| 24 | NKTREUR | Nektar Therapeutics | — | EXIT | Sold out |
| 25 | A | Agilent Technologies INC | — | NEW | New buy |
| 26 | ✓ | Wright Med Group INC | — | EXIT | Sold out |
| 27 | NBIX | Neurocrine Biosciences INC | — | NEW | New buy |
| 28 | BMY | Bristol-myers Squibb Co | — | NEW | New buy |
| 29 | ✓ | Wright Medical Group NV | — | NEW | New buy |
| 30 | ✓ | Depomed INC | — | NEW | New buy |
| 31 | ✓ | St Jude Med INC | — | NEW | New buy |
| 32 | MASI* | Masimo CORP | — | NEW | New buy |